Mayleben Timothy M
SEC-identified person · CIK 1242613 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Marinus Pharmaceuticals, INC. NASDAQMRNS | Director | filed 2014 - 2025 |
| Landos Biopharma, Inc. LABP | Director · Interim CEO | filed 2021 - 2024 |
| Esperion Therapeutics, Inc. ESPR | Director · President and CEO | filed 2013 - 2021 |
| Loxo Oncology, Inc. LOXO | Director | filed 2015 - 2019 |
| Vericel Corp astm | Director · President and CEO | filed 2006 - 2012 |
| Nighthawk Radiology Holdings Inc NHWK | Director · Exec. VP & Chief Operating Off | filed 2006 - 2008 |
| Aksys LTD AKSY | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.